Rimonabant — Tablet (IR, oral)

المنتج المرجعي للتكافؤ الحيوي · Rimonabant

MoleculeRimonabant
Dosage formTablet (IR, oral)
Reference comparatorAcomplia (Sanofi)
TierD
Recommended BE approachNot applicable — do NOT use as comparator (originator withdrawn for safety)
NoteWithdrawn 2008-09 (EU) — serious psychiatric effects (depression / suicidality)
Illustrative harmonised register entry for the Arab markets. Confirm the definitive comparator with the authority of each market before use.
سجل استرشادي موحد · يلزم تأكيد المقارن النهائي من سلطة كل سوق قبل الاستخدام.

Search the interactive Register (375 entries) · the full table · how to cite

Share: LinkedIn · X · WhatsApp · Telegram · Email

Cite as: AUPAM Experts' Office, Rimonabant (Tablet (IR, oral)) — bioequivalence reference product — AUPAM Register, retrieved 2026-08-31, https://aupameo.org/datasets/register/rimonabant-s360.html